Provider review
Vitals Vault review
By The Dose Brief Desk · Updated
Compounded GLP-1 plans billed every four weeks, with a separate $20 clinical review and optional lab testing. Confirm the selected dose, renewal and dispensing eligibility.
Not rated. This review examines published program information; it is not a firsthand treatment review.
At a glance
- Semaglutide
- Compounded semaglutide with glycine and B12 advertised at $157 every four weeks; $20 clinical review is a separate initial charge
- Tirzepatide
- Compounded tirzepatide with glycine and B12 advertised at $169 every four weeks; $20 clinical review is separate
- Availability
- Clinical and pharmacy availability depend on the patient’s physical location and partner authorization; a complete medication-specific state roster was not established.
- Treatment formats
- Clinician-reviewed compounded weekly semaglutide/glycine/B12 and tirzepatide/glycine/B12 injections; laboratory purchases have separate rules.
If a renewing medication plan is selected, charges follow its disclosed schedule until canceled. The $20 review is not a credit toward medication and is refunded if treatment is not prescribed.
In this review
Four-week billing differs from a calendar month
The semaglutide page (opens in a new tab) advertises $157 every four weeks. The tirzepatide page (opens in a new tab) advertises $169 on the same interval. Weekly illustrations of $39.25 and $42.25 describe those charges; they are not weekly payment plans. Confirm the prescribed dose and supplied quantity before assuming every formulation costs the displayed rate.
A continuous twenty-eight-day schedule produces thirteen charges over fifty-two weeks, rather than twelve calendar-month charges. Some page comparisons use monthly language, so use the explicit four-week billing disclosure when budgeting. Our billing-cycle guide explains the difference without converting the advertised plan into an unsupported calendar-month price.
The $20 clinical review is a separate payment
The checkout terms (opens in a new tab) say the initial consultation fee pays the assigned medical group for independent review. It is not a medication deposit or credit. If treatment is prescribed, the full selected medication-plan price is collected separately before pharmacy fulfillment. Completing intake does not guarantee a prescription.
If the clinician does not prescribe treatment, the review fee is refunded to the original payment method. That specific protection does not make an approved medication plan generally refundable. Ask which amount is collected now, when the medication charge occurs and how the selected plan renews; retain those disclosures alongside the clinical consent.
Labs are optional, and their refund rules differ
The medication pages describe recommended testing as unnecessary to start and show an RX-Metabolic Panel at $37.99, with possible additional lab-visit charges confirmed during purchase. A separate promotion offers a progress panel after three months for qualifying starts between November 1 and January 31. Do not assume the promotion covers every test or continues indefinitely.
The refund policy (opens in a new tab) generally allows lab refunds before specimen collection and limits them after collection. That lab protection is separate from medication cancellation. Ask which testing your clinician recommends and whether it costs extra; our lab-cost checklist can help organize the questions.
Clinical decisions and dispensing belong to named partners
The medical-partner disclosure (opens in a new tab) names MDI Medical Group and AYARX Providers as possible clinical groups. It says the actual group is identified before intake, consent and payment. Vitals Vault describes itself as the technology and administrative coordinator, rather than the medical practice or employer of those clinicians.
Strive Specialties, doing business as Strive Pharmacy, is named for dispensing where authorized. Quest Diagnostics is named for laboratory services. These are the platform’s disclosures, not independent license verification or proof of eligibility in every state. Confirm your assigned clinician and pharmacy with our verification guide. The two compounded preparations are not FDA-approved.
Cancel renewal before the order reaches fulfillment
The checkout terms (opens in a new tab) permit charging at each disclosed renewal until cancellation. Canceling stops future renewals but does not undo consultation already provided or medication already ordered, dispensed, shipped or otherwise made available. Request the precise cutoff for your next charge through the account or support before relying on a cancel-anytime message.
The prescription refund policy (opens in a new tab) treats dispensed medication as generally nonreturnable, while preserving remedies for damaged, incorrect, missing or otherwise problematic supplies. The useful comparison is the full twenty-eight-day plan plus the separate review and any labs, with written confirmation of dose and renewal. Our refund checklist helps distinguish ending future billing from reversing a completed order.
What stands out
- Clearly discloses every-four-week medication billing
- Separates the review fee and clinical-nonapproval refund
- Names potential medical groups, dispensing pharmacy and lab partner
What to check
- The $20 review is additional to approved medication charges
- Selected-dose pricing and state eligibility need confirmation
- Optional lab and medication purchases have different refund cutoffs
Sources and review scope
Public information checked in November 2026. Prices and eligibility can change. We have not enrolled in treatment, independently tested medications or verified the licenses of the clinicians and pharmacies involved in an individual prescription. Compounded medications are not FDA-approved; studies of approved brands do not establish that a compounded product has the same safety or effectiveness.
- Semaglutide/B12 price, four-week cadence and optional testing (opens in a new tab)
- Tirzepatide/glycine/B12 plan and testing conditions (opens in a new tab)
- Separate charges, renewal and fulfillment limits (opens in a new tab)
- Clinical nonapproval, lab and medication refund distinctions (opens in a new tab)
- Medical-group, pharmacy and lab roles (opens in a new tab)